Radiometer, REF:956-552, PIC050- Arterial Blood Sampler 1 X 2 mL, 80 IU electrolyte-balanced hepa...
FDA Device Recall #Z-1115-2022 — Class II — April 8, 2022
Recall Summary
| Recall Number | Z-1115-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 8, 2022 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Radiometer Medical ApS |
| Location | Bronshoj, N/A |
| Product Type | Devices |
| Quantity | 7,228 boxes (100 units per box) |
Product Description
Radiometer, REF:956-552, PIC050- Arterial Blood Sampler 1 X 2 mL, 80 IU electrolyte-balanced heparin. Not for injection. , IVD, Rx Only, Sterile EO, CE
Reason for Recall
Arterial Blood Sampler sterility cannot be guaranteed throughout the shelf life of the product.
Distribution Pattern
Worldwide distribution - US Nationwide distribution in the states of AZ, CA, CO, DC, FL, GA, IL, KS, KY, LA, MA, MD, MI, MN, MO, MT, NC, ND, NM, NY, OH, OK, OR, PA, TN, TX, WA, WI and the countries of Canada, Italy, Norway, Austria, Algeria, Argentina, Bolivia, Bosnia, Brazil, Burkina, Faso, Chile, Colombia, Cyprus, Ecuador, Egypt, Eswatin, Ethiopia, Greece, Guatemala, Israel, Lebanon, Libya, Lithuania, Malawi, Nicaragua, Romania, Senegal, Serbia, Slovenia, Thailand, Uganda, Uruguay, Vietnam, Zimbabwe, Belgium, Netherlands, China, Macao, Croatia, Hungary, Denmark, Iceland, Germany, Spain, Portugal, India, Japan, United Kingdom, Ireland, Russia, Australia, Switzerland, France, Czech Republic, Slovakia, South Africa, Botswana, Namibia, Poland, Turkey, Georgia, Sweden, Finland, Estonia, Kazakhstan, Malaysia, Hong Kong.
Lot / Code Information
"All Lots" UDI/DI: 05700699565525
Other Recalls from Radiometer Medical ApS
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1659-2025 | Class II | Radiometer ABL90 Series - Radiometer ABL90 FLEX... | Mar 21, 2025 |
| Z-2426-2024 | Class II | ABL800 FLEX Model Numbers 393-800 and 393-801 ... | May 31, 2024 |
| Z-1394-2023 | Class II | AQURE REF 933-599 Software Versions 2.5.2 2... | Mar 8, 2023 |
| Z-1321-2022 | Class II | ABL800 Flex Analyzer Model Numbers 393-800 and ... | May 18, 2022 |
| Z-1857-2021 | Class II | Radiometer ABL90 FLEX PLUS Analyzer with E3800 ... | Apr 14, 2021 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.